Gianfranco Grompone

This inventor holds 10 USPTO granted patents and 3 published patent applications, plus 6 CIPO patents and 9 EPO patents. Top assignees: Compagnie Gervais Danone, Biopolis, S.l., National Institute for Agricultural Research. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gianfranco Grompone. Retrieved from https://idiyas.com/inventor/gianfranco-grompone

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 3)

% Patents Active = 90.0

CIPO Patents = 6

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 14(Granted Patents)

Company Filing History:

10 out of 136

Compagnie Gervais Danone

National Institute for Agricultural Research

patents

4. 1 out of 269

Pierre Fabre Medicament

patents

where one patent can have more than one assignee

Years Active: 2013-2020

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10548928 - Use offor promoting recovery of the intestinal microbiota diversity after dysbiosis (2020-02-04),

2. 10064902 - [object Object] (2018-09-04),

3. 9855304 - [object Object] (2018-01-02),

4. 9402872 - Probiotic strains for use in improving transepithelial resistance (2016-08-02),

5. 9198940 - Probiotic strains for use in improving the enteric nervous system (2015-12-01),

6. 9056123 - [object Object] (2015-06-16),

7. 8735089 - Method for selecting bacteria with anti-oxidant action (2014-05-27),

8. 8734784 - [object Object] (2014-05-27),

9. 8697054 - [object Object] (2014-04-15),

10. 8557561 - [object Object] (2013-10-15),

Title: Gianfranco Grompone: Innovator in Intestinal Microbiota Recovery

Introduction

Gianfranco Grompone is a notable inventor based in Paris, France. He has made significant contributions to the field of microbiota research, holding a total of 10 patents. His work focuses on promoting recovery of intestinal microbiota diversity, particularly after dysbiosis.

Latest Patents

Grompone's latest patents include innovative methods for maintaining or increasing intestinal microbiota diversity in subjects suffering from dysbiosis. One of his notable inventions relates to a novel strain of a specific species, which is capable of improving the function of the enteric nervous system. This invention also encompasses compositions that utilize this novel strain, showcasing his commitment to advancing health through microbiota research.

Career Highlights

Throughout his career, Grompone has worked with prominent companies such as Compagnie Gervais Danone and Biopolis, S.L. His experience in these organizations has allowed him to apply his research in practical settings, contributing to the development of products aimed at enhancing gut health.

Collaborations

Grompone has collaborated with esteemed colleagues, including Isabelle Chambaud and Sophie Legrain-Raspaud. These partnerships have enriched his research and expanded the impact of his inventions in the scientific community.

Conclusion

Gianfranco Grompone's innovative work in the field of intestinal microbiota recovery highlights his dedication to improving health outcomes. His patents and collaborations reflect a commitment to advancing scientific knowledge and practical applications in microbiota research.

Profile summary based on public USPTO records.